About Us
We are a company founded in 1952 that is dedicated and committed, in our animal health division, to the research, development, manufacture, and commercialization of vaccines, pharmaceuticals, disinfectants, and anti-mycotoxin binders for animal health.
Avimex® has a relevant market share in Mexico, focused on the prevention and control of high impact production animal diseases, in the Poultry, Swine, Dairy and Aquaculture industries.
Awards









+2500
million vaccine doses per year
+29
years preventing Avian Influenza
+30
countries with Avimex® presence
+72 years in the market

Quality
In Avimex® Animal Health, we seek to satisfy our customers’ needs through safe and efficacious veterinary products, that comply with their specifications and official standards, maintaining a Quality Management System (QMS) based on the guidelines of

R&D
Our business strategy is based on the research and development of bio-innovative vaccines to prevent, in a better way, key animal health problems. We have two R&D laboratories, one in Queretaro City that is exclusively focused on technological platforms for vectorized vaccines; and a second one based in Mexico City where we perform molecular biology research on field isolates. Additionally, the company has BSL-3 Isolation Units for experimentation purposes. The Mexico’s National Council for Humanities, Science and Technology (Consejo Nacional de Humanidades, Ciencia y Tecnología - CONAHCYT) has supported us in carrying out research projects, thus, we are considered part of the National Register of Scientific and Technological Institutions and Companies (RENIECYT)
Worldwide Presence
In Avimex® we have global suppliers on 4 continents and more than 50 countries.
Our distributors


